GE HealthCare Technologies(us:GEHC)
78.57
-0.43%
Updated on 2024-12-23
Open:78.78
Close:78.57
High:78.93
Low:77.53
Pre Close:78.91
Volume:1.23M
Amount:96.82M
Turnover:0.27%
Shares:456.87M
MarketCap:35.90B
| Date | Total | Total Shares | Total Ratio | New | Increased | Decreased |
|---|---|---|---|---|---|---|
| 2024-06-30 | 65 | 855546 | 0.19% | 4 | 24 | 19 |
| 2024-03-31 | 1280 | 334605159 | 73.32% | 157 | 432 | 478 |
| 2023-12-31 | 1213 | 310014764 | 68.08% | 153 | 392 | 485 |
| 2023-09-30 | 1187 | 302031444 | 66.35% | 116 | 394 | 483 |
| 2023-06-30 | 1158 | 298460771 | 65.62% | 138 | 404 | 434 |
| 2023-03-31 | 1547 | 278214491 | 61.20% | 88 | 303 | 1099 |
| 2022-12-31 | 1598 | 274278661 | 247 | 413 | 723 |
| date | orgName | total | ratio | changeShares | changeRatio |
|---|---|---|---|---|---|
| 2024-06-30 | Capital Research Global Investors | 54146786 | 11.86% | 154863 | 0.29% |
| 2024-06-30 | Vanguard Group Inc | 48991497 | 10.73% | 472157 | 0.97% |
| 2024-06-30 | Blackrock Inc. | 33874485 | 7.42% | 2828652 | 9.11% |
| 2024-06-30 | State Street Corp | 17268776 | 3.78% | -2291674 | -11.72% |
| 2024-06-30 | Dodge & Cox | 16713150 | 3.66% | -100634 | -0.60% |
| 2024-06-30 | Geode Capital Management, Llc | 10243938 | 2.24% | 1685364 | 19.69% |
| 2024-06-30 | T. Rowe Price Investment Management, Inc. | 8068293 | 1.77% | -15705 | -0.19% |
| 2024-06-30 | Egerton Capital (Uk) Llp | 7357885 | 1.61% | -1348969 | -15.49% |
| 2024-06-30 | Price T Rowe Associates Inc /Md/ | 7334157 | 1.61% | -2627361 | -26.38% |
| 2024-06-30 | Alliancebernstein L.P. | 6842540 | 1.50% | 886105 | 14.88% |
About
GE Healthcare Technologies, Inc. engages in the development and manufacturing of medical technology, pharmaceutical diagnostics, and digital solutions. It operates through the following segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment provides scanning devices, clinical applications, service capabilities and digital solutions. The Ultrasound segment offers screening, diagnosis, treatment, and monitoring of certain diseases. The Patient Care Solutions segment specializes in providing medical devices, consumables, services, and digital solutions. The Pharmaceutical Diagnostics segment supplies diagnostic agents to the global radiology and nuclear medicine community. The company’s history roots back to the year 1892 and it was incorporated on May 16, 2022 and is headquartered in Chicago, IL.
Address:500 West Monroe Street
Website:http://www.gehealthcare.com
Market Movers